Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery
This study has been completed.
Information provided by:
First received: November 25, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
The purpose of this study is to study the effects of N-acetylcysteine on pulmonary function in high-risk patients undergoing off-pump coronary bypass surgery.
|Study Design:||Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Yonsei University:
|Placebo Comparator: N-acetylcysteine , saline||
Drug: N-acetylcysteine, saline
Inject 100 mg/kg of N-acetylcysteine or the equivalent amount of saline for 15 minutes before the skin incision, then continuously inject 40 mg/kg/day of N-acetylcysteine or the equivalent amount of saline during the next 24 hours.
Contacts and Locations